جستجوی استاد راهنمای دانشگاهی

• Outcomes Research
• Endophthalmitis
• Epidemiology of Ophthalmic Disease
• +۵ مورد دیگر

Colin A. McCannel is a Clinical Professor of Ophthalmology at the University of California, Los Angeles (UCLA) Stein Eye Institute . With clinical expertise in vitreoretinal surgical conditions—including complex retinal detachments, macular holes, epimacular membranes, diabetic retinopathy, and age-related macular degeneration (AMD)—he combines advanced surgical practice with innovative research initiatives. MD from Mayo Medical School Residency & Retina Fellowship at UCLA Faculty at Stein Eye Institute since 2008 Research Focus : Outcomes research in retinal surgery, endophthalmitis prevention, and virtual reality (VR) surgical training integration. He pioneered VR into ophthalmology residency and fellowship curricula, revolutionizing skill acquisition. Article Trends (2022-2025) span AMD management, radiation retinopathy, intraocular lymphoma, and surgical simulation. Keywords include Ophthalmology , Retinal Surgery , and Medical Education , with sub-fields like Anti-VEGF Therapy and Gene Expression Profiling . Scientific Awards highlight his leadership: multiple American Academy of Ophthalmology honors (2016 Senior Achievement Award), Innovation in Education (2008), and early career fellowships (Heed, Jules Stein). He serves as a core lecturer at the European Vitreoretinal Training School since 2002. Virtual Reality Initiatives at Stein Eye Institute demonstrate his commitment to surgical education. His work bridges clinical excellence with technological innovation, ensuring trainees master procedures like 27-gauge vitrectomy and McCannel Plaque Stitch techniques.

Steven Sanisloمشاهده پروفایل

استاد بالینی

• Ophthalmology
• Vitreoretinal Surgery
• Retinal Diseases
• +۷ مورد دیگر

Steven Sanislo is a Clinical Professor in the Department of Ophthalmology at Stanford University School of Medicine, where he serves as the senior vitreoretinal surgeon. He maintains an active clinical practice at the Stanford Byers Eye Institute, specializing in vitreoretinal surgery and the medical treatment of complex retinal diseases, including age-related macular degeneration, diabetic retinopathy, macular holes, and retinal detachments. He is deeply involved in teaching ophthalmology residents and retina fellows, and contributes to clinical research on retinal conditions. Education and Training: Medical Education: University of Michigan School of Medicine (1991) Internship: Santa Clara Valley Medical Center (1992) Residency: Stanford University Ophthalmology Residency (1996) Fellowship: Cleveland Clinic Foundation in Vitreoretinal Surgery (1988) Board Certification: American Board of Ophthalmology (2009) Research Interests: Dr. Sanislo's research focuses on improving clinical outcomes in retinal diseases, particularly through early intervention, surgical innovation, and understanding disease progression. His work includes studies on visual acuity outcomes in retinal detachment, anti-VEGF therapy in retinopathy of prematurity, and the role of ophthalmic examination in systemic diseases like Susac syndrome. He has also contributed to operational research aimed at enhancing efficiency in retina clinics. Publication Trends: His recent publications span clinical case reports, retrospective studies, and quality improvement research. The articles emphasize timely surgical intervention, diagnostic accuracy using advanced imaging (e.g., intraoperative OCT), and systemic implications of retinal findings. Key themes include retinal detachment management, macular pathology, and interdisciplinary diagnosis. Professional Affiliations: American Academy of Ophthalmology (1998–Present) Association for Research in Vision and Ophthalmology (1998–Present) American Board of Ophthalmology, Diplomat (1988–Present) American Society of Retina Specialists (1998–Present) Retina Society (2005–Present) Advising and Grants: Dr. Sanislo mentors ophthalmology trainees through structured independent studies, including Early Clinical Experience in Ophthalmology (OPHT 280), Directed Reading (OPHT 299), and research courses for medical and undergraduate students. While specific grant funding is not detailed, his research contributions suggest involvement in clinical and translational studies supported by institutional or collaborative funding. He is actively engaged in improving patient care systems and surgical outcomes in retina. Labs and Clinical Teams: He is a key member of the Stanford Byers Eye Institute’s vitreoretinal team, contributing to both clinical care and academic leadership in retinal diseases. His work integrates closely with multidisciplinary teams in neurology, pediatrics, and immunology, especially in complex diagnostic cases.

Matthew P Simunovicمشاهده پروفایل

استاد

• Ophthalmology
• Vision Science
• Retinal Gene Therapy
• +۱۰ مورد دیگر

Professor Matthew P Simunovic is a surgeon-scientist at the University of Sydney , leading the Retinal Disease and Rescue Group . His clinical and research expertise focuses on retinal diseases, particularly inherited retinal blindness in children and adults, through translational research from laboratory investigations to clinical trials. Clinical interests: Adult and paediatric medical retina, vitreoretinal surgery Research focus: Optogenetics, retinal gene therapy, sub-retinal injection techniques Key achievements: First vitreoretinal surgeon in Southern Hemisphere to perform Luxturna gene therapy; developed NIH/UCL/Oxford color discrimination test Grants & Funding : Secured >$4 million as Principal Investigator 2024 Rewarding Research Excellence (University of Sydney) 2023 NHMRC Equipment Grant 2022-2027 Medical Research Future Fund (Co-PI) Awards : First Australian ophthalmologist supported by Foundation Fighting Blindness Career Development Award Admitted to American Ophthalmological Society and Macula Society (USA) Multiple scholarships from Bayer, RANZCO, and Foulkes Foundation

• Complement System
• Age-related Macular Degeneration (AMD)
• Retinal Degeneration
• +۳ مورد دیگر

Camilla Mohlin is a researcher at Linnaeus University , affiliated with the Faculty of Health and Life Sciences and the Department of Chemistry and Biomedical Sciences . Her work primarily focuses on the complement system , age-related macular degeneration (AMD) , and retinal degeneration . Her ongoing research projects include: Advanced Materials for Personalized Medicine & Diagnostics (AMPMeD) Chronic inflammation in AMD patients treated with anti-VEGF injections Complement regulators in AMD pathophysiology Key publication trends span immunology , neuroscience , and nanomedicine , with sub-fields like complement regulation , retinal neuroinflammation , and nanoparticle toxicity . She has published in journals such as: Graefe's Archives for Clinical and Experimental Ophthalmology (2025) Frontiers in Immunology (2023) Journal of Molecular Biology (2023)

Yuanwei Zhangمشاهده پروفایل

دانشیار

• Near-infrared (NIR) fluorophores
• Biomaterials development
• Optogenetics
• +۴ مورد دیگر

Yuanwei Zhang is an Associate Professor in the Department of Chemistry and Environmental Science at the New Jersey Institute of Technology (NJIT). His research focuses on developing near-infrared (NIR)-light-responsive organic chromophores and biomaterials for applications in biomedical imaging, optogenetics, and photodynamic therapy. Zhang completed his B.S. and M.S. in Chemistry from Nankai University (2005, 2008), followed by a Ph.D. in Chemistry from the University of Central Florida (2013). His postdoctoral work at the University of Massachusetts Medical School expanded his expertise in optogenetic techniques and animal studies. His educational background includes: B.S., Chemistry, Nankai University (2005) M.S., Chemistry, State Key Laboratory of Elemento (2008) Ph.D., Chemistry, University of Central Florida (2013) Zhang’s research interests span organic synthesis, photonic materials, and biomedical applications. His lab develops NIR fluorophores for sensors, drug delivery systems, and imaging tools. Notable trends in his publications include advancements in upconversion nanomaterials, pH-sensitive photosensitizers, and label-free microscopy techniques. His work bridges organic chemistry and biomedical engineering, with applications in cancer therapy, cellular imaging, and energy storage materials. Zhang’s lab focuses on interdisciplinary projects at the interface of chemistry and biology. Current efforts include designing injectable retinal nanoantennae for NIR vision enhancement and developing scalable methods for PEGylated polymers in gene delivery. His research also explores the use of BODIPY-based compounds for light-activated drug release and cellular targeting.